UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.010

Sortiert nach

role for interleukin-6 in spreading endothelial cell activation after phagocytosis of necrotic trophoblastic material: implications for the pathogenesis of pre-eclampsia

The Journal of pathology, 2009, Vol.217 (1), p.122-130

2009

Volltextzugriff (PDF)

Identification of human-selective analogues of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

British journal of cancer, 2013-04, Vol.108 (6), p.1306-1315

2013

Volltextzugriff (PDF)

Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice

British journal of cancer, 2004-02, Vol.90 (4), p.906-910

2004

Volltextzugriff (PDF)

Induction of endothelial cell apoptosis by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid

British journal of cancer, 2002-06, Vol.86 (12), p.1937-1942

2002

Volltextzugriff (PDF)

Dissection of stromal and cancer cell-derived signals in melanoma xenografts before and after treatment with DMXAA

British journal of cancer, 2012-03, Vol.106 (6), p.1134-1147

2012

Volltextzugriff (PDF)

Development of a wide-range soft sensor for predicting wastewater BOD5 using an eXtreme gradient boosting (XGBoost) machine

Environmental research, 2022-07, Vol.210, p.112953-112953, Article 112953

2022

Volltextzugriff (PDF)

Vitamin C Enhances Phagocytosis of Necrotic Trophoblasts by Endothelial Cells and Protects the Phagocytosing Endothelial Cells from Activation

Placenta (Eastbourne), 2009-02, Vol.30 (2), p.163-168

2009

Volltextzugriff (PDF)

The antitumour agent 5,6-dimethylxanthenone-4-acetic acid acts in vitro on human mononuclear cells as a co-stimulator with other inducers of tumour necrosis factor

European journal of cancer (1990), 2001-10, Vol.37 (15), p.1930-1937

2001

Volltextzugriff (PDF)

Thalidomide increases both intra-tumoural tumour necrosis factor-α production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid

British journal of cancer, 1999-05, Vol.80 (5-6), p.716-723

1999

Volltextzugriff (PDF)

Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice

Cancer research (Chicago, Ill.), 1999-07, Vol.59 (14), p.3304-3307

1999

Volltextzugriff (PDF)

Stimulation of tumors to synthesize tumor necrosis factor-α in situ using 5,6-dimethylxanthenone-4-acetic acid : A novel approach to cancer therapy

Cancer research (Chicago, Ill.), 1999-02, Vol.59 (3), p.633-638

1999

Volltextzugriff (PDF)

NF-kappa B activation in vivo in both host and tumour cells by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

European journal of cancer (1990), 2003-05, Vol.39 (8), p.1176-1183

2003

Volltextzugriff (PDF)

Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity

British journal of cancer, 1998-08, Vol.78 (3), p.336-343

1998

Volltextzugriff (PDF)

Antiphospholipid antibodies bind to activated but not resting endothelial cells: is an independent triggering event required to induce antiphospholipid antibody-mediated disease?

Thrombosis research, 2004, Vol.114 (2), p.101-111

2004

Volltextzugriff (PDF)

Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acid

British journal of cancer, 1995-08, Vol.72 (2), p.339-343

1995

Volltextzugriff (PDF)

The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout mice

British journal of cancer, 2002-08, Vol.87 (4), p.465-470

2002

Volltextzugriff (PDF)

Production of tumour necrosis factor-α by cultured human peripheral blood leucocytes in response to the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (NSC 640488)

British journal of cancer, 1997, Vol.76 (12), p.1586-1591

1997

Volltextzugriff (PDF)

Modulation of the pharmacokinetics of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice by thalidomide

Cancer chemotherapy and pharmacology, 2000, Vol.46 (2), p.135-141

2000

Volltextzugriff (PDF)

Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid

Anticancer research, 1998-11, Vol.18 (6A), p.4409

1998

Volltextzugriff (PDF)

Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

Cancer research (Chicago, Ill.), 2001-02, Vol.61 (4), p.1517-1521

2001

Volltextzugriff (PDF)

Activation of LPS-inducible genes by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid in primary murine macrophages. Dissection of signaling pathways leading to gene induction and tyrosine phosphorylation

The Journal of immunology (1950), 1994-11, Vol.153 (10), p.4684

1994

Volltextzugriff (PDF)

Antitumour responses to flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid in immune deficient mice

British journal of cancer, 1992-07, Vol.66 (1), p.128-130

1992

Volltextzugriff (PDF)

Thalidomide Pharmacokinetics and Metabolite Formation in Mice, Rabbits, and Multiple Myeloma Patients

Clinical cancer research, 2004-09, Vol.10 (17), p.5949-5956

2004

Volltextzugriff (PDF)

Metabolism of thalidomide in liver microsomes of mice, rabbits, and humans

The Journal of pharmacology and experimental therapeutics, 2004-08, Vol.310 (2), p.571

2004

Volltextzugriff (PDF)

Tunable infrared laser absorption spectroscopy of aluminum monoxide A 2 Π i − X 2 Σ

Journal of quantitative spectroscopy & radiative transfer, 2022-03, Vol.279 (C), p.108029, Article 108029

2022

Volltextzugriff (PDF)

1 – 25 von 1.010

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(882)
Mit Volltextzugriff
(898)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(835)
Life Sciences & Biomedicine
(636)
Humans
(482)
Biological And Medical Sciences
(372)
Male
(334)
Female
(315)
Medical Sciences
(293)
Animals
(247)
Middle Aged
(146)
Adult
(142)
Technology
(142)
Oncology
(130)
Mice
(128)
Aged
(118)
Adolescent
(102)
Pharmacology. Drug Treatments
(100)
Fundamental And Applied Biological Sciences. Psychology
(96)
Child
(95)
Physical Sciences
(95)
Engineering
(85)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

role for interleukin-6 in spreading endothelial cell activation after phagocytosis of necrotic trophoblastic material: implications for the pathogenesis of pre-eclampsia

Identification of human-selective analogues of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice

Induction of endothelial cell apoptosis by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid

Dissection of stromal and cancer cell-derived signals in melanoma xenografts before and after treatment with DMXAA

Development of a wide-range soft sensor for predicting wastewater BOD5 using an eXtreme gradient boosting (XGBoost) machine

Vitamin C Enhances Phagocytosis of Necrotic Trophoblasts by Endothelial Cells and Protects the Phagocytosing Endothelial Cells from Activation

The antitumour agent 5,6-dimethylxanthenone-4-acetic acid acts in vitro on human mononuclear cells as a co-stimulator with other inducers of tumour necrosis factor

Thalidomide increases both intra-tumoural tumour necrosis factor-α production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid

Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice

Stimulation of tumors to synthesize tumor necrosis factor-α in situ using 5,6-dimethylxanthenone-4-acetic acid : A novel approach to cancer therapy

NF-kappa B activation in vivo in both host and tumour cells by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity

Antiphospholipid antibodies bind to activated but not resting endothelial cells: is an independent triggering event required to induce antiphospholipid antibody-mediated disease?

Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acid

The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout mice

Production of tumour necrosis factor-α by cultured human peripheral blood leucocytes in response to the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (NSC 640488)

Modulation of the pharmacokinetics of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice by thalidomide

Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid

Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

Activation of LPS-inducible genes by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid in primary murine macrophages. Dissection of signaling pathways leading to gene induction and tyrosine phosphorylation

Antitumour responses to flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid in immune deficient mice

Thalidomide Pharmacokinetics and Metabolite Formation in Mice, Rabbits, and Multiple Myeloma Patients

Metabolism of thalidomide in liver microsomes of mice, rabbits, and humans

Tunable infrared laser absorption spectroscopy of aluminum monoxide A 2 Π i − X 2 Σ

Suchergebnisse filtern